Phreesia Swings to Profit on Strong Revenue Growth, Cost Controls

Ticker: PHR · Form: 10-Q · Filed: Sep 5, 2025 · CIK: 1412408

Phreesia, INC. 10-Q Filing Summary
FieldDetail
CompanyPhreesia, INC. (PHR)
Form Type10-Q
Filed DateSep 5, 2025
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$0.01
Sentimentbullish

Sentiment: bullish

Topics: Healthcare Technology, SaaS, Financial Performance, Revenue Growth, Profitability, Acquisition Integration, Digital Health

Related Tickers: PHR

TL;DR

**PHR's swing to profit is a strong buy signal, showing their growth strategy and cost discipline are finally paying off.**

AI Summary

Phreesia, Inc. reported a significant turnaround in its financial performance for the three months ended July 31, 2025, achieving a net income of $654 thousand, a substantial improvement from the net loss of $18.012 million in the same period last year. Total revenues increased by 14.8% to $117.255 million from $102.115 million year-over-year, driven by growth across all segments: subscription and related services rose to $53.702 million (up from $48.612 million), payment processing fees increased to $28.392 million (up from $25.300 million), and network solutions grew to $35.161 million (up from $28.203 million). Despite the revenue growth, total expenses remained relatively stable at $118.762 million compared to $119.337 million, primarily due to reduced sales and marketing expenses, which decreased to $25.396 million from $30.184 million. The company's operating loss narrowed dramatically to $1.507 million from $17.222 million, indicating improved operational efficiency. Cash and cash equivalents increased to $98.266 million as of July 31, 2025, from $84.220 million at January 31, 2025, bolstering liquidity. Key risks include intense competition, challenges in managing future growth, and the unique operational risks of being a fully remote company, alongside the pending AccessOne Acquisition integration.

Why It Matters

This turnaround to profitability is a critical signal for investors, demonstrating Phreesia's ability to scale revenue while controlling costs, especially in a competitive healthcare technology market. For employees, this improved financial health could mean greater job security and potential for growth within the company. Customers benefit from a more stable and innovative partner, particularly as Phreesia integrates AI into its offerings and expands through acquisitions like AccessOne. In the broader market, Phreesia's performance highlights the increasing demand for technology-enabled healthcare services and the potential for digital health platforms to achieve profitability, setting a benchmark for competitors.

Risk Assessment

Risk Level: medium — The risk level is medium due to the company's reliance on a rapidly evolving and competitive industry, as highlighted by the 'highly competitive industry' risk factor. Additionally, the pending 'AccessOne Acquisition' introduces integration risks and potential dilution for stockholders, which could impact future financial performance despite the current positive trend.

Analyst Insight

Investors should consider initiating or increasing positions in PHR, given the strong revenue growth across all segments and the significant swing to net income. Monitor the integration of the AccessOne Acquisition closely, as successful integration will be key to sustaining this positive momentum and realizing long-term value.

Financial Highlights

debt To Equity
0.04
revenue
$117.255 million
operating Margin
-1.3%
total Assets
$408.629 million
total Debt
$11.672 million
net Income
$0.654 million
eps
N/A
gross Margin
N/A
cash Position
$98.266 million
revenue Growth
+14.8%

Revenue Breakdown

SegmentRevenueGrowth
Subscription and related services$53.702 million+10.5%
Payment processing fees$28.392 million+12.2%
Network solutions$35.161 million+24.6%

Key Numbers

Key Players & Entities

FAQ

What were Phreesia's total revenues for the quarter ended July 31, 2025?

Phreesia's total revenues for the three months ended July 31, 2025, were $117.255 million, an increase from $102.115 million in the same period of 2024.

Did Phreesia achieve net income or loss in the latest quarter?

Phreesia achieved a net income of $654 thousand for the three months ended July 31, 2025, a significant improvement from a net loss of $18.012 million in the prior year's comparable quarter.

How did Phreesia's operating loss change year-over-year?

Phreesia's operating loss narrowed substantially to $1.507 million for the three months ended July 31, 2025, compared to an operating loss of $17.222 million for the same period in 2024.

What are the key revenue streams for Phreesia, Inc.?

Phreesia's key revenue streams include subscription and related services ($53.702 million), payment processing fees ($28.392 million), and network solutions ($35.161 million) for the quarter ended July 31, 2025.

What is the status of the AccessOne Acquisition for Phreesia?

The AccessOne Acquisition is pending, and Phreesia has identified it as a potential source of integration challenges, diversion of management resources, unanticipated costs, or dilution to stockholders.

What are the primary risks Phreesia faces in its business operations?

Phreesia faces risks including operating in a highly competitive industry, challenges in managing future growth, privacy concerns, cyber-attacks, and the unique operational risks associated with being a fully remote company.

How has Phreesia's cash position changed?

Cash and cash equivalents for Phreesia increased to $98.266 million as of July 31, 2025, from $84.220 million as of January 31, 2025.

What impact does Artificial Intelligence (AI) have on Phreesia's business?

AI presents both risks and challenges for Phreesia, including potential security risks to confidential information, increased regulatory and compliance burdens, and heightened competition, as stated in the risk factors.

Where can investors find more information about Phreesia?

Investors can find more information about Phreesia on their investor relations website at https://ir.phreesia.com, through press releases, SEC filings, public conference calls, and various social media channels listed in the 10-Q.

What was Phreesia's sales and marketing expense for the quarter?

Phreesia's sales and marketing expense for the three months ended July 31, 2025, was $25.396 million, a decrease from $30.184 million in the same period of 2024.

Risk Factors

Industry Context

Phreesia operates within the rapidly evolving healthcare technology sector, specifically focusing on patient intake, engagement, and payment solutions. The industry is characterized by a strong push towards digital transformation, interoperability, and value-based care models. Key trends include the increasing adoption of SaaS platforms by healthcare providers to streamline operations, improve patient experience, and manage revenue cycles more effectively.

Regulatory Implications

As a healthcare technology company, Phreesia must navigate stringent regulations related to data privacy and security, particularly HIPAA. Compliance with these regulations is critical to avoid significant penalties and maintain customer trust. Changes in healthcare policy or reimbursement structures could also indirectly impact the demand for Phreesia's services.

What Investors Should Do

  1. Monitor the integration of the AccessOne Acquisition.
  2. Evaluate the sustainability of expense reductions, particularly in Sales & Marketing.
  3. Assess the impact of competition on pricing power and market share.

Key Dates

Glossary

Deferred contract acquisition costs
Costs incurred to obtain contracts with customers that are expected to be recovered. These are capitalized and amortized over the expected customer life. (An increase in these costs can indicate successful sales efforts, but also requires careful monitoring of recoverability.)
Accumulated deficit
The total net losses of a company since its inception, less any net gains. It represents the cumulative loss that has not been offset by profits. (A large accumulated deficit, though reduced by recent profitability, highlights the company's history of losses and the importance of sustained profitability.)
Settlement assets/obligations
Assets and liabilities arising from payment processing activities, representing funds held temporarily for transactions between customers and merchants. (These are operational balances directly tied to the payment processing segment of the business.)

Year-Over-Year Comparison

Phreesia has demonstrated a significant financial turnaround compared to the prior year's filing. Total revenues increased by 14.8% to $117.255 million, driven by robust growth across all segments. Crucially, the company achieved a net income of $654 thousand, a dramatic improvement from a net loss of $18.012 million in the same period last year. This profitability was aided by a notable reduction in sales and marketing expenses, which fell from $30.184 million to $25.396 million, leading to a narrowed operating loss. Cash reserves also strengthened, increasing from $84.220 million to $98.266 million, enhancing liquidity.

Filing Stats: 4,681 words · 19 min read · ~16 pages · Grade level 19.1 · Accepted 2025-09-05 16:02:27

Key Financial Figures

Filing Documents

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION Item 1 .

Financial Statements

Financial Statements: Consolidated Balance Sheets as of July 31, 2025 (unaudited) and January 31, 2025 8 Consolidated Statements of Operations for the Three and Six Months Ended July 31, 2025 and 2024 (unaudited) 9 Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended July 31, 2025 and 2024 (unaudited) 10 Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended July 31, 2025 and 2024 (unaudited) 11 Consolidated Statements of Cash Flows for the Three and Six Months Ended July 31, 2025 and 2024 (unaudited) 13 Notes to Unaudited Consolidated Financial Statements 15

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 35

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 48

Controls and Procedures

Item 4. Controls and Procedures 49

— OTHER INFORMATION

PART II — OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 50

Risk Factors

Item 1A. Risk Factors 50

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 82

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 82

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 82

Other Information

Item 5. Other Information 82

Exhibits

Item 6. Exhibits 84

Signatures

Signatures 86 3 Table of Contents Summary of Material Risks Associated with our Business Our business is subject to numerous risks and uncertainties that you should be aware of in evaluating our business. These risks and uncertainties include, but are not limited to, the following: We operate in a highly competitive industry, and if we are not able to compete effectively, including with the electronic health records ("EHR") and practice management ("PM") systems with which we integrate, our business and results of operations may be harmed. If we fail to manage our future growth effectively, our revenue may not increase, and we may be unable to implement our business strategy. Our operating results have fluctuated and may continue to fluctuate significantly and if we fail to meet the expectations of analysts or investors, our stock price and the value of your investment could decline substantially. Privacy concerns, cyber-attacks, data breaches or cybersecurity incidents relating to our SaaS-based solutions could result in economic loss, damage to our reputation, deterring users from using our products, and our exposure to legal penalties and liability. Our operations in India subject us to additional risks which could have an adverse effect on our business, operating results, and financial condition . We typically incur significant upfront costs in our client relationships, and if we are unable to develop or grow these relationships over time, we are unlikely to recover these costs and our operating results may suffer. As a result of our variable sales and implementation cycles, we may be unable to recognize revenue to offset expenditures, which could result in fluctuations in our quarterly results of operations or otherwise harm our future operating results. The estimates and assumptions we use to determine the size of our target market may prove to be inaccurate, and even if the markets in which we compete meet our size estimates and forecasted gro

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Phreesia, Inc. Consolidated Balance Sheets (in thousands, except share and per share data) July 31, 2025 January 31, 2025 (Unaudited) Assets Current: Cash and cash equivalents $ 98,266 $ 84,220 Settlement assets 28,875 29,176 Accounts receivable, net of allowance for doubtful accounts of $ 2,654 and $ 1,468 as of July 31, 2025 and January 31, 2025, respectively 76,842 73,617 Deferred contract acquisition costs 431 401 Prepaid expenses and other current assets 18,227 15,871 Total current assets 222,641 203,285 Property and equipment, net of accumulated depreciation and amortization of $ 90,765 and $ 84,505 as of July 31, 2025 and January 31, 2025, respectively 22,769 23,651 Capitalized internal-use software, net of accumulated amortization of $ 62,272 and $ 55,991 as of July 31, 2025 and January 31, 2025, respectively 53,881 52,763 Operating lease right-of-use assets 1,043 1,477 Deferred contract acquisition costs 551 583 Intangible assets, net of accumulated amortization of $ 10,147 and $ 8,407 as of July 31, 2025 and January 31, 2025, respectively 26,403 28,143 Goodwill 75,845 75,845 Deferred tax asset 1,640 — Other assets 3,856 2,668 Total Assets $ 408,629 $ 388,415 Liabilities and Stockholders' Equity Current: Settlement obligations $ 28,875 $ 29,176 Current portion of finance lease liabilities and other debt 7,096 8,043 Current portion of operating lease liabilities 941 964 Accounts payable 6,527 5,622 Accrued expenses 34,783 37,460 Deferred revenue 26,913 32,758 Total current liabilities 105,135 114,023 Long-term finance lease liabilities and other debt 4,576 8,150 Operating lease liabilities, non-current 179 646 Long-term deferred revenue 81 119 Long-term deferred tax liabilities 626 484 Other long-term liabilities 45 185 Total Liabilities 110,642 123,607 Commitments and contingencies (Note 11) Stockholders' Equity: Preferred stock, undesignated, $ 0.01 par value— 20,000,000 shares aut

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing